Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers.
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingConcomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumoursDabrafenib in combination with trametinib for the treatment of metastatic melanoma.Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review.Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approachesPimasertib, a selective oral MEK1/2 inhibitor: absolute bioavailability, mass balance, elimination route, and metabolite profile in cancer patients.
P2860
Q23923997-896CA94F-54FF-4089-A2A6-A5EA1481F7D0Q34571039-42D5528D-EF2E-47EB-8B12-3592CB2AD742Q38282958-C380E31B-A9EB-4482-A93B-7DB10C994252Q38836158-21F3A116-26A5-482F-88E2-72150EAFF77CQ38849629-2DAD6B9F-294E-420A-AECD-FA6989A9090AQ41880361-816C7823-21BD-4B0C-8B42-ECC91EBC75F4Q45383453-117C1ADD-AB96-4AF3-B6EA-F36D4BF5CABF
P2860
Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@en
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@nl
type
label
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@en
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@nl
prefLabel
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@en
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@nl
P2093
P2860
P1433
P1476
Trametinib, a first-in-class o ...... ubjects with advanced cancers.
@en
P2093
Carolyn B Pendry
Donna S Cox
Jill L Pirhalla
John W Bauman
Keith W Orford
May Y K Ho
Michael J Morris
Royce A Morrison
P2860
P304
P356
10.3109/00498254.2013.831143
P407
P577
2013-08-23T00:00:00Z